Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Introduction to the Formulation & Stabilisation of Protein and Peptide Drugs    Back

European Continuing Education College Course Type: Short courses (CPD) Start Date: To be announced
Duration: Full time - 2 Days Fees/total cost: EUR 1,495.00


The course provides attendees with

  • a perspective on the importance of formulation development in the biopharmaceutical industry
  • an understanding of the most common mechanisms of protein degradation
  • an overview of where pharmaceutical macromolecules are most likely to be damaged during handling and storage
  • the physical basis for the aggregation and solubility behaviour of polypeptides
  • descriptions of the most important analytical tools needed in formulation development
  • detailed strategies for stabilization of proteins and chemically modified proteins.

In addition to lectures, the course will include group exercises for evaluating the suitability of various formulations of pharmaceutial proteins

Key Benefits of Attending

Pharmaceutical macromolecules, whether proteins or peptides, are highly susceptible to degradation throughout the development process. From the time the active pharmaceutical ingredient is synthesized, it is subjected to stresses that can induce damage. For example, the processes of isolation, purification, formulation, packaging, and storage each provide opportunities for chemical and physical changes to occur with potentially disastrous consequences to the final product. This course will provide a detailed overview of the common methods of degradation for proteins, as well as the most current strategies for stabilisation and formulation of pharmaceutical macromolecules. Emphasis will be placed on a mechanistic, rather than a phenomenological approach, towards stabilisation of peptides and proteins. Special emphasis will be given to the differences between peptides and proteins.

Who Should Attend

Anyone involved in the development of pharmaceutical macromolecules as commercial therapeutic agents, whether for human or veterinary use. This course is intended for those new to the field and those who simply wish to obtain an overview of this important discipline. This would include those involved in research & development, production, purification, formulation, manufacturing, and delivery of peptides and proteins. Those involved in overseeing these operations would benefit as well as those working at the bench.

Course contact information

Information ECEC
Last update: 14/05/2018